These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1367 related items for PubMed ID: 9402652

  • 21. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J, Rabbani SA, Shibata HR, Brodt P.
    J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
    [Abstract] [Full Text] [Related]

  • 22. Urokinase receptor variants in tissue and body fluids.
    Høyer-Hansen G, Lund IK.
    Adv Clin Chem; 2007 May; 44():65-102. PubMed ID: 17682340
    [Abstract] [Full Text] [Related]

  • 23. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB, Taylor M, Grøndahl-Hansen J, Kakolyris S, Gatter KC, Harris AL.
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [Abstract] [Full Text] [Related]

  • 24. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V, Whawell SA, Werner F, Deadman JJ.
    Biochemistry; 1999 Jan 12; 38(2):651-9. PubMed ID: 9888805
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The role of plasminogen activator receptor in cancer invasion and dormancy.
    Ossowski L, Aguirre Ghiso J, Liu D, Yu W, Kovalski K.
    Medicina (B Aires); 1999 Jan 12; 59(5 Pt 2):547-52. PubMed ID: 10684157
    [Abstract] [Full Text] [Related]

  • 27. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U, Magdolen V, Hapke S, Schmitt M.
    Biol Chem; 2003 Aug 12; 384(8):1119-31. PubMed ID: 12974381
    [Abstract] [Full Text] [Related]

  • 28. Protease crosstalk with integrins: the urokinase receptor paradigm.
    Chapman HA, Wei Y.
    Thromb Haemost; 2001 Jul 12; 86(1):124-9. PubMed ID: 11486997
    [Abstract] [Full Text] [Related]

  • 29. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
    Binder BR, Mihaly J, Prager GW.
    Thromb Haemost; 2007 Mar 12; 97(3):336-42. PubMed ID: 17334498
    [Abstract] [Full Text] [Related]

  • 30. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 12; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 31. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 12; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 32. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT.
    J Cell Sci; 2004 Jan 26; 117(Pt 3):477-85. PubMed ID: 14679304
    [Abstract] [Full Text] [Related]

  • 33. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG.
    J Cell Physiol; 2005 Jul 26; 204(1):73-82. PubMed ID: 15573379
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ, McCaffrey TA, Mathew J, McAdam K, Borth W.
    J Cell Physiol; 1995 Aug 26; 164(2):334-43. PubMed ID: 7622580
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.
    Tecimer C, Doering DL, Goldsmith LJ, Meyer JS, Abdulhay G, Wittliff JL.
    Gynecol Oncol; 2001 Jan 26; 80(1):48-55. PubMed ID: 11136569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 69.